Search hospitals > North Carolina > Durham
Duke Comprehensive Cancer Center
Claim this profileDurham, North Carolina 27705
Global Leader in Brain Tumor
Global Leader in Solid Tumors
Conducts research for Breast Cancer
Conducts research for Lung Cancer
Conducts research for Cancer
625 reported clinical trials
36 medical researchers
Summary
Duke Comprehensive Cancer Center is a medical facility located in Durham, North Carolina. This center is recognized for care of Brain Tumor, Solid Tumors, Breast Cancer, Lung Cancer, Cancer and other specialties. Duke Comprehensive Cancer Center is involved with conducting 625 clinical trials across 395 conditions. There are 36 research doctors associated with this hospital, such as Angeles A. Secord, Harry P. Erba, Jeffrey M. Clarke, and Richard Riedel, MD.Area of expertise
1Brain Tumor
Global LeaderStage IV
HER2 positive
Stage III
2Solid Tumors
Global LeaderStage IV
Stage III
HER2 positive
Top PIs
Angeles A. SecordDuke University Medical Center4 years of reported clinical research
Expert in Ovarian Cancer
Studies Endometrial Cancer
18 reported clinical trials
31 drugs studied
Harry P. ErbaDuke University Medical Center7 years of reported clinical research
Expert in Acute Myelogenous Leukemia
Expert in Acute Myeloid Leukemia
18 reported clinical trials
35 drugs studied
Jeffrey M. ClarkeDuke Cancer Institute3 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
12 reported clinical trials
20 drugs studied
Richard Riedel, MDDuke University5 years of reported clinical research
Studies Cancer
Studies Soft Tissue Sarcoma
12 reported clinical trials
19 drugs studied
Clinical Trials running at Duke Comprehensive Cancer Center
Breast Cancer
Ovarian Cancer
Cancer
Colorectal Cancer
Solid Tumors
Lung Cancer
Fallopian Tube Cancer
Pancreatic Cancer
Brain Tumor
Non-Hodgkin's Lymphoma
Sacituzumab Govitecan + Pembrolizumab
for Triple Negative Breast Cancer
The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surgery, is effective and safe compared to the treatment of physician's choice (TPC) which includes either pembrolizumab or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after surgery and pre-surgical treatment.
Recruiting2 awards Phase 36 criteria
Zanidatamab vs Trastuzumab
for Breast Cancer
The efficacy and safety of zanidatamab in combination with physician's choice of chemotherapy compared with trastuzumab in combination with physician's choice of chemotherapy will be evaluated for the treatment of participants with metastatic HER2-positive breast cancer who have progressed on, or are intolerant to, previous T-DXd treatment.
Recruiting2 awards Phase 34 criteria
SRG-514
for Breast Cancer
This is a multicenter, first-in-human (FIH), open label, Phase 1 dose escalation and recommended Phase 2 dose (RP2D) extension trial with a primary objective to define the RP2D of SRG-514 when administered intraoperatively to patients undergoing breast-conserving cancer surgery. SRG-514 will be investigated utilizing a 3+3 convention dose escalation cohorts.
Recruiting1 award Phase 13 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Duke Comprehensive Cancer Center?
Duke Comprehensive Cancer Center is a medical facility located in Durham, North Carolina. This center is recognized for care of Brain Tumor, Solid Tumors, Breast Cancer, Lung Cancer, Cancer and other specialties. Duke Comprehensive Cancer Center is involved with conducting 625 clinical trials across 395 conditions. There are 36 research doctors associated with this hospital, such as Angeles A. Secord, Harry P. Erba, Jeffrey M. Clarke, and Richard Riedel, MD.
Where is Duke Comprehensive Cancer Center located?
To reach the Duke Comprehensive Cancer Center in Durham, NC:
- Take the 147 Durham Freeway Exit (Exit 279 B) from I-40, then the Elba Street/Trent Drive Exit (Exit 15 A).
- Enter the left lane and turn left into the Parking Deck on your left before the next light.
- For accessible transportation, use the Duke Van Service by calling 919.684.2020.
Who should I call to ask about financial aid or insurance network?
For insurance-related inquiries at Duke Comprehensive Cancer Center, contact DCU Insurance at 508.263.6978, email insurance@dcu.org, or fax 866.897.2629. For financial assistance, reach out to the Financial Relief Program at 800-723-2210. For debt and budget management, contact BALANCE at 888.456.2227.
What insurance does Duke Comprehensive Cancer Center accept?
The Duke Comprehensive Cancer Center accepts a variety of insurance plans, including commercial health insurance plans (Aetna, Blue Cross Blue Shield of North Carolina, CIGNA Healthcare of NC, Humana, Optima Health, Progyny, United Healthcare) with HMO, POS, and PPO options. Coverage extends to pharmacy and behavioral health benefits. The center also accepts exchange health insurance plans from Healthcare.gov, Medicare Advantage Plans, and Medicaid Managed Care.
What awards or recognition has Duke Comprehensive Cancer Center received?
The Duke Comprehensive Cancer Center in Durham, North Carolina, is renowned for its significant research funding and groundbreaking studies. It has received a $6,693 award from 5 for the Fight for "Dr. Anders-Cancer Research" and a $1,932,000 award from the Department of Defense for "DoD: PCRP Clinical Consortium: Duke University Clinical Research Site". The center is also recognized for its research into racial differences in breast cancer outcomes, highlighting the disparity in chemotherapy response between Black and white women for triple negative breast cancer.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.